In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.
London, United Kingdom – 1 September 2024: An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined ...
FAMOUS-NSTEMI is the latest clinical trial to assess benefits of St. Jude Medical PressureWireTM technology in expanded patient populations ST. PAUL, Minn. & BARCELONA, Spain -- St. Jude Medical, Inc.
An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death or MI, although ...
The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision-making. However, emerging ...
Patients with a history of cocaine use who present with non-ST-segment elevation myocardial infarction have a lower risk of future major adverse cardiovascular events if treated invasively rather than ...
The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...
DelveInsight's, “Myocardial Infarction Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction pipeline landscape. It covers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results